Methods and compositions for immuno-histochemical detection

• US 8,632,994 B2
• Filed: 11/30/2004
• Issued: 01/21/2014
• Est. Priority Date: 12/01/2003
• Status: Active Grant

• Current Assignee: Agilent Technologies, Inc.
• Original Assignee: Dako Denmark A/S (Agilent Technologies, Inc.)
• Inventors: Winther, Lars, Knoll, Anthony Lionel, Weckworth, Kellyann, Lovborg, Uffe
• Primary Examiner(s): FOSTER, CHRISTINE E
• Application Number:
  US10/999,102
• Publication Number:
  US 20050208529A1
• Time in Patent Office: 3,339 Days
• Field of Search: None
• US Class Current: 435/40.5
• CPC Class Codes: G01N 2474/20 Immunohistochemistry assay
• CPC Class Codes: G01N 33/543 with an insoluble carrier for immobilising immunochemicals
• CPC Class Codes: G01N 33/54306 Solid-phase reaction mechanisms
• CPC Class Codes: G01N 33/58 involving labelled substances G01N33/53 takes precedence

Abstract

The invention relates to methods and compositions of detecting a biological marker in a sample. In certain embodiments, the methods and compositions comprise a first binding agent that specifically binds to a biological marker in a sample; a second binding agent linked to a first polymer, wherein the second binding agent specifically binds to the first binding agent; a third binding agent linked to a second polymer, wherein the third binding agent specifically binds to the second binding agent; and a detectable substance. In certain embodiments the biological markers are detected immunologically.

Claims

1. A method of detecting a biological marker in a sample comprising:

a. contacting the sample with at least one first binding agent that specifically binds to the biological marker in the sample such that the at least one first binding agent binds to the sample and forms a first complex;

b. contacting the first complex of a) with at least one second binding agent that specifically binds to the at least one first binding agent such that a second complex is formed, wherein the at least one second binding agent is linked to at least one first polymer;

c. contacting the second complex of b) with at least one third binding agent that specifically binds to the at least one second binding agent, wherein the at least one third binding agent is linked to at least one second polymer;

wherein at least one detectable agent is linked to at least one of

i. the at least one third binding agent;

ii. the at least one second polymer;

or

iii. both the at least one third binding agent and the at least one second polymer;

wherein the at least one third binding agent binds to the second complex of b) and forms a third complex; and

d. detecting the at least one detectable agent of the third complex of c), thereby detecting the biological marker in the sample.

2. The method of claim 1, wherein the at least one first binding agent is a primary antibody or a nucleic acid probe.

3. The method of claim 2, wherein the at least one first binding agent is a primary antibody derived from any mammalian or avian species.

4. The method of claim 3, wherein the primary antibody is derived from a rat, mouse, pig, goat, rabbit, sheep, guinea pig, donkey, llama, camel, or horse.

5. The method of claim 1, wherein the at least one second binding agent is a dual linked binding agent.

6. The method of claim 1, wherein the at least one second binding agent is a secondary antibody.

7. The method of claim 6, wherein the secondary antibody is derived from any mammalian species except the mammalian species from which the primary antibody is derived.

8. The method of claim 7, wherein the secondary antibody is derived from a rat, mouse, pig, goat, rabbit, sheep, guinea pig, donkey, llama, camel, or horse.

9. The method of claim 1, wherein the at least one second binding agent is at least one of fos, jun, major histocompatibility complex (MHC), C1q, an immunoglobulin receptor, or any molecule comprising a leucine zipper domain.

10. The method of claim 9, wherein the at least one second binding agent further comprises an Fc region of an antibody.

11. The method of claim 9, wherein the at least one second binding agent is an MHC molecule, and wherein the MHC molecule is MHC class I, MHC class II, or non-conventional MHC.

12. The method of claim 1, wherein the at least one third binding agent is a tertiary antibody.

13. The method of claim 12, wherein the tertiary antibody is derived from any mammalian species except the mammalian species from which the primary antibody and secondary antibody are derived.

14. The method of claim 13, wherein the tertiary antibody is derived from a rat, mouse, pig, goat, rabbit, sheep, guinea pig, donkey, llama, or horse.

15. The method of claim 12, wherein the tertiary antibody binds to a hapten molecule linked to at least one of:

i. the at least one second binding agent;

ii. the at least one first polymer;

or

iii. the at least one second binding agent and the at least one first polymer.

16. The method of claim 15, wherein the hapten is FITC, DNP, Digoxigenin, nitrotyrosine biotin, avidin, streptavidin, or an anti-dye antibody.

17. The method of claim 1, wherein the at least one third binding agent is fos, jun, major histocompatibility complex (MHC), C1q, an immunoglobulin receptor, or any molecule having a leucine zipper domain.

18. The method of claim 17, wherein the at least one third binding agent further comprises an Fc region of an antibody.

19. The method of claim 17, wherein the MHC molecule is MHC class I or MHC class II.

20. The method of claim 1, wherein the sample is a tissue sample.

21. The method of claim 1, wherein the sample is a cell sample.

22. The method of claim 1, wherein the sample is a mammalian sample.

23. The method of claim 22, wherein the mammalian sample is a human sample.

24. The method of claim 1, wherein the biological marker in the sample is a protein.

25. The method of claim 24, wherein the protein in the sample is expressed at higher or lower levels in a cell obtained from a subject having a disease compared to a cell obtained from a subject not having the disease.

26. The method of claim 1, wherein the sample is provided on a solid support.

27. The method of claim 26, wherein the solid support is a microscope slide, a solid support capable of being inspected under a microscope, or a solid support capable of being used to produce photomicrographs.

28. The method of claim 1, wherein the at least one second binding agent linked to the at least one first polymer comprises two different secondary antibodies linked to two different polymers, each of the two secondary antibodies comprising an antigen binding domain which specifically binds to the at least one first binding agent, wherein the at least one first binding agent comprises two different primary antibodies derived from different mammalian sources.

29. The method of claim 28, wherein the primary antibodies are derived from a rat, mouse, pig, goat, rabbit, sheep, guinea pig, donkey, llama, or horse.

30. The method of claim 1, further comprising at least one second detectable agent linked to at least one of

a. the at least one first polymer;

b. the at least one second binding agent;

or

c. both the at least one first polymer and the at least one second binding agent.

31. The method of claim 30, wherein the at least one first and second detectable agents are the same agent.

32. The method of claim 30, wherein the at least one first and second detectable agents are different agents.

33. The method of claim 30, wherein the at least one first and second detectable agents are fluorescent labels, enzyme labels, radioisotopes, chemiluminescent labels, bioluminescent labels, polymers, metal particles, haptens, antibodies, or dyes.

34. The method of claim 33, wherein the at least one first and second detectable agents are 5-(and 6)-carboxyfluorescein, 5- or 6 -carboxyfluorescein, 6-(fluorescein)-5-(and 6)-carboxamido hexanoic acid, fluorescein isothiocyanate, rhodamine, tetramethylrhodamine, Cy2, Cy3, Cy5, AMCA, PerCP, R-phycoerythrin (RPE), allophycoerythrin (APC), Texas Red, Princeton Red, Green fluorescent protein (GFP), coated CdSe nanocrystallites, DNP, biotin, digoxiginin, horseradish peroxidase (HRP), alkaline phosphatase (AP), beta-galactosidase (GAL), glucose-6-phosphate dehydrogenase, beta-N-acetylglucosaminidase, β

-glucuronidase, invertase, Xanthine Oxidase, firefly luciferase, glucose oxidase (GO), luminol, isoluminol, acridinium esters, 1,2 -dioxetanes, 1,2-pyridopyridazines, or radioactive isotopes of hydrogen, carbon, sulfur, iodide, cobalt, selenium, tritium, or phosphorous.

35. The method of claim 1, wherein at least one of the first binding agent, the second binding agent, and the third binding agent is an antibody.

36. The method of claim 35 wherein the antibody is a monoclonal antibody.

37. The method of claim 1, further comprising two second binding agents wherein each second binding agent is individually linked to at least one separate polymer.

38. The method of claim 1, wherein at least one of the at least one first polymer and the at least one second polymer comprises natural polysaccharides, synthetic polysaccharides, polyethylene glycol-containing polymer backbones, polypropylene glycol-containing polymer backbones, poly(ethylene oxide-co-propylene oxide)-containing polymer backbones, linear dendrimers, comb-shaped dendrimers, branched dendrimers, poly amino acids, proteins, polynucleotides, or oligonucleotide dendrimer constructs.

39. The method of claim 38, wherein the polymer is a mixed polymer comprising two or more of the following:

natural polysaccharides, synthetic polysaccharides, polyethylene glycol-containing polymer backbones, polypropylene glycol-containing polymer backbones, poly(ethylene oxide-co-propylene oxide)-containing polymer backbones, linear dendrimers, comb-shaped dendrimers, branched dendrimers, poly amino acids, polynucleotides, or oligonucleotide dendrimer constructs.

40. The method of claim 39, wherein the polysaccharides comprise dextrans, cyclodextrins, pullulans, schizophyllan, scleroglucan, xanthan, gellan, O-ethylamino guaran, chitins, chitosans, derivatized cellulosics, hydroxylated starch, hydroxypropyl starch, hydroxyethyl starch, carrageenans, alginates, or agarose;

the synthetic polysaccharides comprise vinyl polymers;

the poly amino acids comprise polylysines, polyglutamic acid, polyurethanes, or poly(ethylene imines);

the proteins comprise albumins or immunoglobulins; and

the polynucleotides comprise DNA, peptide nucleic acid (PNA), locked nucleic acid (LNA), or oligonucleotides.

41. The method of claim 40, wherein the dextrans comprise carboxy methyl dextran, dextran polyaldehyde, or carboxymethyl dextran lactone;

the vinyl polymers comprise poly(acrylic acid), poly(acryl amides), poly(acrylic esters), poly(2-hydroxy ethyl methacrylate), poly(methyl methacrylate), poly(maleic acid), poly(maleic anhydride), poly(acrylamide), poly(ethyl-co-vinyl acetate), poly(methacrylic acid), poly(vinylalcohol), poly(vinyl alcohol-co-vinyl chloroacetate), aminated poly(vinyl alcohol), or co block polymers thereof;

the chitins comprise 6-O-carboxymethyl chitin;

the chitosans comprise N-carboxymethyl chitosan; and

the derivatized cellulosics comprise carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, hydroxyethyl cellulose, 6-amino-6-deoxy cellulose, or O-ethylamine cellulose.

42. The method of claim 38, wherein if at least one of the at least one first polymer and the at least one second polymer comprises natural polysaccharides, the natural polysaccharides comprise dextrans, cyclodextrins, pullulans, schizophyllan, scleroglucan, xanthan, gellan, O-ethylamino guaran, chitins, chitosans, derivatized cellulosics, hydroxylated starch, hydroxypropyl starch, hydroxyethyl starch, carrageenans, alginates, or agarose;

or if at least one of the at least one first polymer and the at least one second polymer comprises synthetic polysaccharides, the synthetic polysaccharides comprise vinyl polymers;

or if ata least one of the at least one first polymer and the at least one second polymer comprises poly amino acids, the poly amino acids comprise polylysines, polyglutamic acid, polyurethanes, or poly(ethylene imines);

or if at least one of the at least one first polymer and the at least one second polymer comprises proteins, the proteins comprise albumins or immunoglobulins;

or if at least one of the at least one first polymer and the at least one second polymer comprises polynucleotides, the polynucleotides comprise DNA, peptide nucleic acid (PNA), locked nucleic acid (LNA), or oligonucleotides.

43. The method of claim 42, wherein if at least one of the at least one first polymer and the at least one second polymer comprises dextrans, the dextrans comprise carboxy methyl dextran, dextran polyaldehyde, or carboxymethyl dextran lactone;

or if at least one of the at least one first polymer and the at least one second polymer comprises vinyl polymers, the vinyl polymers comprise poly(acrylic acid), poly(acryl amides), poly(acrylic esters), poly(2-hydroxy ethyl methacrylate), poly(methyl methacrylate), poly(maleic acid), poly(maleic anhydride), poly(acrylamide), poly(ethyl-co-vinyl acetate), poly(methacrylic acid), poly(vinylalcohol), poly(vinyl alcohol-co-vinyl chloroacetate), aminated poly(vinyl alcohol), or co block polymers thereof;

or if at least one of the at least one first polymer and the at least one second polymer comprises chitins, the chitins comprise 6-O-carboxymethyl chitin;

or if at least one of the at least one first polymer and the at least one second polymer comprises chitosans, the chitosans comprise N-carboxymethyl chitosan;

or if at least one of the at least one first polymer and the at least one second polymer comprises derivatized celllulosics, the derivatized cellulosics comprise carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, hydroxyethyl cellulose, 6-amino-6-deoxy cellulose, or O-ethylamine cellulose.

44. The method of claim 1, wherein at least one of the first polymer and the second polymer comprises dextran.

45. A method of detecting a biological marker in a sample comprising

a. contacting the sample with at least one primary mouse or rabbit antibody that specifically binds to the biological marker in the sample, such that the at least one primary antibody binds to the sample forming a first complex;

b. contacting the first complex of a) with

i. at least one first secondary goat antibody linked to at least one first polymer, the at least one first secondary goat antibody comprising an antigen binding domain that specifically binds to a mouse antibody; and

ii. at least one second secondary goat antibody linked to at least one second polymer, the at least one second secondary goat antibody comprising an antigen binding domain that specifically binds to a rabbit antibody,

such that at least one secondary antibody binds to the first complex of a) forming a second complex;

c. contacting the second complex of b) with at least one tertiary rabbit antibody linked to at least one third polymer, the at least one tertiary rabbit antibody comprising an antigen binding domain that specifically reacts with a goat antibody;

wherein at least one horseradish peroxidase molecule is linked to at least one of

1. the at least one tertiary antibody;

2. the at least one third polymer;

or

3. both the at least one tertiary antibody and the at least one third polymer;

wherein the at least one tertiary antibody binds to the second complex of b) and forms a third complex; and

d. detecting the horseradish peroxidase of the third complex of c), thereby detecting the biological marker in the sample.

46. A method of detecting a biological marker in a sample comprising

a. contacting the sample with at least one primary mouse antibody that specifically binds to the biological marker in the sample such that the at least one primary mouse antibody binds to the sample forming a first complex;

b. contacting the first complex of a) with at least one rabbit secondary antibody linked to at least one first polymer, the at least one rabbit secondary antibody comprising an antigen binding domain that specifically reacts with a mouse antibody such that the at least one rabbit antibody specifically binds to the first complex of a) forming a second complex;

c. contacting the second complex of b) with at least one tertiary goat antibody linked to at least one second polymer, the at least one tertiary goat antibody comprising an antigen binding domain that specifically binds to a rabbit antibody;

wherein at least one horseradish peroxidase molecule is linked to at least one of

1. the at least one tertiary antibody;

2. the at least one second polymer;

or

3. both the at least one tertiary antibody and the at least one second polymer

wherein the at least one tertiary antibody binds to the second complex of b) and forms a third complex; and

d. detecting the horseradish peroxidase of the third complex of c), thereby detecting the biological marker in the sample.

47. A method of detecting a biological marker in a sample comprising

a. contacting the sample with at least one primary mouse antibody that specifically binds to the biological marker in the sample such that the at least one primary mouse antibody binds to the sample forming a first complex;

b. contacting the first complex of a) with at least one secondary rabbit antibody linked to at least one first polymer, the at least one secondary rabbit antibody comprising an antigen binding domain which specifically reacts with a mouse antibody such that the at least one secondary antibody binds to the first complex of a) forming a second complex;

c. contacting the second complex of b) with

i. at least one first tertiary goat antibody linked to at least one second polymer, the at least one first tertiary goat antibody comprising an antigen binding domain that specifically binds to a rabbit antibody; and

ii. at least one second tertiary goat antibody linked to at least one third polymer, the at least one second tertiary goat antibody comprising an antigen binding domain which specifically reacts with a mouse antibody;

wherein at least one horseradish peroxidase molecule is linked to at least one of

1. any tertiary antibody;

2. the at least one second polymer;

3. the at least one third polymer;

4. both the at least one second polymer and the at least one third polymer;

or

5. any tertiary antibody and both the at least one second polymer and the at least one third polymer;

wherein the at least one first and second tertiary antibodies bind to the second complex of b and form a third complex; and

d. detecting the horseradish peroxidase of the third complex of c), thereby detecting the biological marker in the sample.

48. The method of claim 47, further comprising at least one horseradish peroxidase molecule linked to

a. the at least one secondary rabbit antibody;

b. the at least one first polymer;

or

c. both the at least one secondary rabbit antibody and the at least one first polymer.

49. A method of detecting a biological marker in a sample comprising

a. contacting the sample with at least one primary mouse or rabbit antibody that specifically binds to the biological marker in the sample, such that the at least one primary antibody binds to the sample forming a first complex;

b. contacting the first complex of a) with at least one second binding agent comprising

i. at least one first secondary goat antibody linked to at least one first polymer, the at least one first secondary goat antibody comprising an antigen binding domain that specifically binds to a mouse antibody;

ii. at least one second secondary goat antibody linked to at least one second polymer, the at least one second secondary goat antibody comprising an antigen binding domain that specifically binds to a rabbit antibody; and

iii. at least one hapten molecule linked to at least one of

1. the first or second secondary goat antibodies;

2. the first or second polymers;

or

3. the first or second secondary goat antibody and the first or second polymers;

such that at least one secondary antibody binds to the first complex of a) forming a second complex;

c. contacting the second complex of b) with at least one tertiary rabbit, mouse, rat, pig, or goat antibody, linked to at least one third polymer, the at least one tertiary antibody comprising an antigen binding domain that specifically binds to at least one hapten molecule of b);

wherein at least one horseradish peroxidase molecule is linked to at least one of

1. the at least one tertiary antibody;

2. the at least one third polymer;

or

3. both the at least one tertiary antibody and the at least one third polymer;

wherein the at least one tertiary antibody binds to the second complex of b) and forms a third complex; and

d. detecting the horseradish peroxidase of the third complex of c), thereby detecting the biological marker in the sample.